Azithromcyin
Azithromcyin is a pharmaceutical drug with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 1 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
1
Mid Stage
3
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
1 of 1 finished
0.0%
0 ended early
1
trials recruiting
4
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial
Short-term Bactericidal Effect of Contezolid in MAC-PD
Non-Surgical Treatment of Peri-implantitis with Systemic Azithromycin or Placebo
Impact of Two Alternative Dosing Strategies for Trachoma Control in Niger
Clinical Trials (4)
Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial
Short-term Bactericidal Effect of Contezolid in MAC-PD
Non-Surgical Treatment of Peri-implantitis with Systemic Azithromycin or Placebo
Impact of Two Alternative Dosing Strategies for Trachoma Control in Niger
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4